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Abstract
Background: Depression is a disorder with high prevalence in primary health care and a significant
burden of illness. The delivery of health care for depression, as well as other chronic illnesses, has
been criticized for several reasons and new strategies to address the needs of these illnesses have
been advocated. Case management is a patient-centered approach which has shown efficacy in the
treatment of depression in highly organized Health Maintenance Organization (HMO) settings and
which might also be effective in other, less structured settings.
Methods/Design: PRoMPT (PRimary care Monitoring for depressive Patients Trial) is a cluster
randomised controlled trial with General Practice (GP) as the unit of randomisation. The aim of
the study is to evaluate a GP applied case-management for patients with major depressive disorder.
70 GPs were randomised either to intervention group or to control group with the control group
delivering usual care. Each GP will include 10 patients suffering from major depressive disorder
according to the DSM-IV criteria. The intervention group will receive treatment based on
standardized guidelines and monthly telephone monitoring from a trained practice nurse. The
nurse investigates the patient's status concerning the MDD criteria, his adherence to GPs
prescriptions, possible side effects of medication, and treatment goal attainment. The control group
receives usual care – including recommended guidelines. Main outcome measure is the cumulative
score of the section depressive disorders (PHQ-9) from the German version of the Prime MD
Published: 05 October 2005
BMC Public Health 2005, 5:101 doi:10.1186/1471-2458-5-101
Received: 05 August 2005
Accepted: 05 October 2005
This article is available from: http://www.biomedcentral.com/1471-2458/5/101
© 2005 Gensichen et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Public Health 2005, 5:101 http://www.biomedcentral.com/1471-2458/5/101
Page 2 of 6
(page number not for citation purposes)
Patient Health Questionnaire (PHQ-D). Secondary outcome measures are the Beck-Depression-
Inventory, self-reported adherence (adapted from Moriskey) and the SF-36. In addition, data are
collected about patients' satisfaction (EUROPEP-tool), medication, health care utilization,
comorbidity, suicide attempts and days out of work.
The study comprises three assessment times: baseline (T0) , follow-up after 6 months (T1) and
follow-up after 12 months (T2).
Discussion: Depression is now recognized as a disorder with a high prevalence in primary care
but with insufficient treatment response. Case management seems to be a promising intervention
which has the potential to bridge the gap of the usually time-limited and fragmented provision of
care. Case management has been proven to be effective in several studies but its application in the
private general medical practice setting remains unclear.
Background
Depression is a significant burden of illness [1,2]. Most
depressed patients are diagnosed and treated by general
practitioners [3,4]. Depression is the third most common
reason for a primary care consultation [5]. Patients with
depression account for 50% higher health care costs
patients than patients who are not depressed [6]. When
improving primary health care for chronic conditions, a
number of problems have to be resolved: discontinuity
and fragmentation of the process of care, lack of co-ordi-
nation between different providers, and "the tyranny of
urgency" [7]. In the management of depression, these def-
icits lead to frequent interruption or premature termina-
tion of drug therapy, which increases the risk of
unfavourable depression outcomes [8,9]. Patient-centred
approaches with a focus on empowerment and self man-
agement have been recommended [10,7,11]. Case Man-
agement may be one approach to improve depression
care. Case Management has been defined as "taking
responsibility for following-up patients; determining
whether patients were continuing the prescribed treat-
ment as intended; assessing whether depressive symp-
toms were improving; and taking action when patients
were not adhering to guideline based treatment or when
they were not showing expected improvement" [12]. Case
Management consists of five essential components: (1)
identification of patients in need of services, (2) assess-
ment of individual patient needs, (3) developing a treat-
ment plan, (4) coordination of care, and (5) monitoring
outcomes and altering care when favourable outcomes are
not achieved [13].
Reviews of controlled trials including our meta-analysis
concluded that Case Management improves patient out-
comes – with a moderate effect [12,14,15]. However,
most of the studies available were conducted in highly
organized Health Maintenance Organizations (HMO) set-
ting using central based stuff to run the intervention.
However, it still remains unclear what the effects in a
peripheral setting as a private general practice based case
management for patients with depression will be like.
Methods/Design
Aim of the study
The study examines the efficacy of a GP based case man-
agement intervention for patients with depression.
Scientific hypothesis
Case management (intervention) leads to greater reduc-
tions in depressive symptoms than usual care (control
group). We hypothesize further that case management
leads to a greater increase in adherence (medication) and
quality of life.
Study design
The study is a (prospective) cluster-randomized two-
armed intervention study with the practices being clusters.
The design of a cluster randomized study was chosen
because with this type of study internal validity (absence
of confounders) can be optimized, contamination of
interventions associated with patient randomization is
not possible.
Sample size
Sample size calculations for cluster randomized trials dif-
fer completely from sample size calculations for common
RCTs [16,17]. Based on the main outcome parameter
depression symptom and the main outcome-assessment
instrument (GERMAN-PHQ) [18] we performed a power
calculation with the method of Hayes and Bennett [19]. It
is provided to record a clinical relevant intervention effect
of the Case Management from yet 10% up to the primary
size, thus an improvement of the depression score (PHQ-
D). Assuming an effect of 35 % (PHQ – Score difference
from 18,6 to 12.9) in intervention group and a effect of 25
% in control [20] (PHQ Score – 18.6 to 12.9) we have to
detect a minimal difference of 1,86. With an alpha of 5%,
a beta of 20%, a SD of 6.1 and a ICC 0.1 we are calculatingBMC Public Health 2005, 5:101 http://www.biomedcentral.com/1471-2458/5/101
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N = 680 (drop-out 30% included). Every arm of the study
(34 practices) has to include 10 Patients.
Recruitment of GPs and randomization
As described above, the GPs form the unit of randomiza-
tion (cluster). It was decided to address and to include
only those practices that have a contract with all German
insurances, because 90 % of care provision is covered by
this type of practices. About 1600 GPs in the city of Frank-
furt and the region near by (federal state of Hessen) were
informed by mail about the study and invited to a meet-
ing. After this meeting, 72 GPs gave their written consent
to participate in the study. Based on detailed information
about the practice and the GP, the inclusion criteria were
checked (no exclusive clinical specialization) and two
practices had to be excluded due to the inclusion criteria.
The 70 GPs were stratified according to the size of the city
where the practice is located and then randomized to the
intervention group or the control group. The procedure
was done by an independent assistant who is not familiar
to one of the participating doctors and is not a person of
the project team. A randomization protocol was written.
(Figure 1)
Case manager inclusion criteria
For the practice nurses who wanted to engage in the study,
the following criteria are recommended: formal training
as practice nurse and at least one year work experience
after completion of formal training, and participation in
the study case management work shops.
Patient inclusion criteria
Adult Patients, diagnosed with a Major Depression Epi-
sode, aged from 18 to 80 years, capability to give
informed consent, sufficient knowledge of the German
language and indication for antidepressive treatment
(medication and/or psychotherapy) can be included.
Diagnostic procedure consists in self-report of depressive
symptoms via PHQ-9 [18] and subsequent validation in a
clinical interview. Participating practices keep an alpha-
betic record of their patients who are already on treat-
ment. Five Patients from this list are contacted in
consecutive order of appearance in the practice and
informed about the option to participate in the study.
After checking the inclusion criteria and receiving the
informed consent, patients receive the questionnaires.
Afterwards, five new patients, fulfilling the same criteria,
are to be recruited on a screening-day.
Data collection
After giving their informed and written consent to partici-
pate in the study patients will receive the questionnaires.
The completed questionnaires will be turned back to the
practice where there a collected from a member of the
project team when the practice has recruited 10 patients.
The envelopes are opened at the university and scanned
("eyes and hands ™ FORMS "-Software, Version 5-2 of
Read Soft). A TIF-file is generated out of each question-
naire to avoid any data-manipulation and to have a
medium for data storage. The scanned data are transferred
into the SPSS files. For documentation and data reporting
in publications CONSORT recommendations for cluster
randomized trials are considered [21].
Outcome-parameter
Table 1 displays the outcome parameters and additionally
used instruments. The primary outcome is the depression
score assessed by the PHQ-9 questionnaire. The PHQ is an
internationally applied instrument for the screening in
primary care of the major mental disorders. The German
version is also validated [18]. Secondary outcomes
include:
• the Beck-Depression-Inventory (BDI) [22]
• self-reported adherence (adapted from Moriskey) [23]
• Quality of life (SF-36) [24]
• Health Care utilization (referrals to specialists, days in
clinic); data retrieved form patients chart
• Patient satisfaction (modified EUROPEP-questionnaire)
[25]
• Suicide attempts
• Days out of work
These data will be compiled from patient questionnaires
and patients chart review. All instruments are well vali-
dated and frequently used in international studies. Assess-
ments are done three times: baseline (T0), follow-up after
6 months (T1) and follow up after 12 months (T2).
Intervention
The practice nurses of the intervention group will be
trained to case manager in two work-shops with the fol-
lowing contents: main features of the disorder, communi-
cation skills, telephone monitoring and documentation.
A follow-up work-shop is scheduled to supervise the tele-
phone-monitoring, and each practice is contacted
bimonthly from the project team to advice concerning
assessment, documentation and intervention.
The intervention comprises the following aspects:
1. The case manager begins with an introduction session
which aims at establishing contact, explaining the patient
his/her function, delivering information about theBMC Public Health 2005, 5:101 http://www.biomedcentral.com/1471-2458/5/101
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disorder and the self-management tools (education). GPs
will also receive a written patient leaflet which provides
information about the cause and the treatment possibili-
ties as well as coping strategies and a list of self help
books.
2. The case manager contacts the patient for telephone
monitoring (10–15 minutes). Based on a structured inter-
view, the case manager will ask the patient first two-
weekly (the first two months) and than in intervals of 4
weeks about the status of depression, adherence, side
effects of medication and goal-attainment (Depression
Monitoring List – DeMol, Gensichen unpublished)
3. After each patient contact, a short report will be given
to the family doctor.
In both the intervention and the control group, GPs will
receive a summary of evidence based treatments of
depression in a primary care setting and these information
contain amongst others, the NHG guidelines. There is no
implementation strategy in the control group.
Timeframe of the study
The study team has already randomized the 70 GPs who
have declared their willingness to participate in the study
and who accepted random assignment to the different
groups. The study protocol was approved by the ethics
commission of the University of Frankfurt (Approval-Nr.
E 26/05).
The patient enrollment has already started and up to now,
about 220 patient are included who completed baseline
assessment.
Description of risks
To our knowledge, serious risks or undesired effects of
completing questionnaires are not reported in the litera-
ture. There are no specific risks related to the study.
Ethical principles
The study is planned and conducted in accordance with
medical professional codex and the Helsinki Declaration
of 1996 as well as the German Federal Data Security Law
(BDSG).
Patients participate in the study voluntarily. They are
informed that they can cancel at any time their participa-
tion without disclosing reasons for their cancellation and
without negative consequences to their future medical
care.
Patient informed consent
Patients receive written and spoken information about the
main features of the study; i.e. about potential benefits for
their health and potential risks prior to their consent and
participation in the study. In case of acceptance, they sign
the informed consent sheet.
In case of study discontinuation data will be extinguished,
except the patient affirms explicitly the further analysis of
his data.
Vote of the ethics committee
The study protocol was approved by the ethics committee
of the University of Frankfurt previous to the start of the
study in April 25, 2005. Inclusion of patients/participants
did not start unless there was a written and unrestricted
positive vote of the ethics committee. This vote was
received in March 2005.
Data security/disclosure of original documents
The patient names and other confidential information are
secured by the medical confidentiality rules and are
treated according to German Federal Data Security Law
(BDSG). The results of the patient questionnaires are not
accessible to the GPs.
Table 1: Outcomes and instruments
Outcome-Parameter (Patient) Instrument
Primary Outcome
Depression PHQ-9
Secondary outcome
Depression BDI (Beck-Depression-Inventar)
Quality of life SF-36
Adherence to medication Adapted version of Moriskey adherence questionnaire
Health care utilization questionnaire, retrospective chart review
Patient satisfaction Modified EUROPEP
Suicide attempts questionnaire
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All study related data and documents are stored on a pro-
tected central server of the Frankfurt University Clinic.
Only members of the study team have access to the respec-
tive files.
Intermediate and final reports are stored in the office of
the Department of General Practice and Health Services
Research at the Frankfurt University Clinic.
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